Production method of crystalline form of clopidogrel 1 hydrogen sulphate

Process for the preparation of substantially pure polymorphic Form 1 of clopidogrel hydrogensulfate, wherein the reaction of optically active clopidogrel base with sulfuric acid is carried out in the mixture of at least two solvents, chosen from group I, comprising aliphatic ethers, and from group I...

Full description

Saved in:
Bibliographic Details
Main Authors WO NIAK ROBERT, KO LUK TOMASZ
Format Patent
LanguageEnglish
Polish
Published 29.09.2008
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Process for the preparation of substantially pure polymorphic Form 1 of clopidogrel hydrogensulfate, wherein the reaction of optically active clopidogrel base with sulfuric acid is carried out in the mixture of at least two solvents, chosen from group I, comprising aliphatic ethers, and from group II, comprising ketones, esters of C1-C3 carboxylic acids and aliphatic alcohols C1-C4, primary, secondary and tertiary aliphatic alcohols C1-C4, then the resulting suspension is stirred until at least 70% of amorphous clopidogrel hydrogensulfate formed is transformed into polymorphic Form 1 of clopidogrel hydrogensulfate, and finally, the crystalline solid is isolated from the reaction mixture and subject to additional work-up procedure, aiming at the formation and stabilization of polymorphic Form 1.
Bibliography:Application Number: PL20070382055